Baxter PD Patient Connectology Singapore - englanti - HSA (Health Sciences Authority)

baxter pd patient connectology

baxter healthcare (asia) pte ltd - general hospital - this device is used for pd disconnect application and where aseptic connections are performed.

ISORRANE INHALATION ANAESTHETIC Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

isorrane inhalation anaesthetic

baxter healthcare pty ltd - isoflurane - parenteral liquid/solution/suspension - isoflurane anaesthetic active 100.0 % - anaesthetics/analgesics - birds - ornamental | cat | dog | horse | reptile | small mammals | amazon parrot | bitch | caged bird | canary | castrate | cat - inhalation anaesthetic

MITOXANTRONE BAXTER SOLUTION FOR INJECTION 20MG10ML (2MGML) Malesia - englanti - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mitoxantrone baxter solution for injection 20mg10ml (2mgml)

baxter healthcare (malaysia) sdn. bhd. - mitoxantrone hydrochloride -

TISSEEL VH S/D fibrin sealant syringe Australia - englanti - Department of Health (Therapeutic Goods Administration)

tisseel vh s/d fibrin sealant syringe

baxter healthcare pty ltd - calcium chloride dihydrate, quantity: 36 micromole/ml; human thrombin, quantity: 400 iu/ml - solution - excipient ingredients: albumin; sodium chloride; water for injections - tissel is indicated: - as adjunct to haemostasis during surgical procedures, when control of bleeding by conventional surgical techniques is ineffective or impractical; and - as a sealant as an adjunct for closure of colostomies. - as a sealant and/or adhesive for use in autologous chrondrocyte implantation (aci) or matrix-induced autologous chondrocyte implantation (maci) procedures. - for mesh fixation in non-iatrogenic abdominal wall hernia repair, as an alternative to sutures, staples or tacks.

SUPRANE desflurane 1g/g inhalation USP bottle Australia - englanti - Department of Health (Therapeutic Goods Administration)

suprane desflurane 1g/g inhalation usp bottle

baxter healthcare pty ltd - desflurane, quantity: 1 g/g - inhalation, conventional - excipient ingredients: - indications: suprane is indicated as an inhalation agent for maintenance of anaesthesia. suprane is not recommended for mask induction of anaesthesia because of a high incidence of moderate to severe upper airway adverse events.

AERRANE isoflurane 1mL/mL inhalation bottle Australia - englanti - Department of Health (Therapeutic Goods Administration)

aerrane isoflurane 1ml/ml inhalation bottle

baxter healthcare pty ltd - isoflurane, quantity: 1 ml/ml - inhalation, conventional - excipient ingredients: - aerrane is a volatile halogenated anaesthetic for general inhalation anaesthesia.

PRIMENE 10% amino acids solution for injection Bottle Australia - englanti - Department of Health (Therapeutic Goods Administration)

primene 10% amino acids solution for injection bottle

baxter healthcare pty ltd - threonine, quantity: 3.7 mg/ml; proline, quantity: 3 mg/ml; glycine, quantity: 4 mg/ml; arginine, quantity: 8.4 mg/ml; tyrosine, quantity: 0.45 mg/ml; valine, quantity: 7.6 mg/ml; leucine, quantity: 10 mg/ml; serine, quantity: 4 mg/ml; isoleucine, quantity: 6.7 mg/ml; cysteine, quantity: 1.89 mg/ml; taurine, quantity: 0.6 mg/ml; lysine, quantity: 11 mg/ml; ornithine monohydrochloride, quantity: 3.18 mg/ml; histidine, quantity: 3.8 mg/ml; alanine, quantity: 8 mg/ml; aspartic acid, quantity: 6 mg/ml; methionine, quantity: 2.4 mg/ml; glutamic acid, quantity: 10 mg/ml; tryptophan, quantity: 2 mg/ml; phenylalanine, quantity: 4.2 mg/ml - injection, intravenous infusion - excipient ingredients: malic acid; water for injections - primene 10% amino acid iv infusion is indicated in infants and neonates at term or premature, for short-term use, of normal or low birth-weight when oral or enteral nutrition is impossible, insufficient or contraindicated. it is used as an amino acid component in a composite admixture of total parenteral nutrition.

BAXTER POTASSIUM CHLORIDE 40 mmol and 0.9% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - englanti - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 40 mmol and 0.9% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 29.8 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER POTASSIUM CHLORIDE 10 mmol and 0.29% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - englanti - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 10 mmol and 0.29% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - sodium chloride, quantity: 2.92 g/l; potassium chloride, quantity: 7.46 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER POTASSIUM CHLORIDE 30 mmol and 0.9% SODIUM CHLORIDE 1000 mL intravenous infusion bag Australia - englanti - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 30 mmol and 0.9% sodium chloride 1000 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 2.24 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.